Free Trial

Pro-Dex (PDEX) Competitors

Pro-Dex logo
$28.40 +0.33 (+1.18%)
Closing price 10/24/2025 04:00 PM Eastern
Extended Trading
$28.34 -0.05 (-0.19%)
As of 10/24/2025 04:10 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

PDEX vs. KIDS, SMLR, TMCI, DCTH, CARL, NPCE, DRTS, TCMD, RXST, and BWAY

Should you be buying Pro-Dex stock or one of its competitors? The main competitors of Pro-Dex include OrthoPediatrics (KIDS), Semler Scientific (SMLR), Treace Medical Concepts (TMCI), Delcath Systems (DCTH), Carlsmed (CARL), NeuroPace (NPCE), Alpha Tau Medical (DRTS), Tactile Systems Technology (TCMD), RxSight (RXST), and Brainsway (BWAY). These companies are all part of the "medical equipment" industry.

Pro-Dex vs. Its Competitors

Pro-Dex (NASDAQ:PDEX) and OrthoPediatrics (NASDAQ:KIDS) are both small-cap medical companies, but which is the better stock? We will compare the two businesses based on the strength of their institutional ownership, earnings, risk, media sentiment, profitability, dividends, analyst recommendations and valuation.

Pro-Dex has higher earnings, but lower revenue than OrthoPediatrics. OrthoPediatrics is trading at a lower price-to-earnings ratio than Pro-Dex, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Pro-Dex$66.59M1.40$8.98M$2.7010.52
OrthoPediatrics$204.73M2.09-$37.82M-$1.79-9.51

Pro-Dex has a net margin of 13.48% compared to OrthoPediatrics' net margin of -18.92%. Pro-Dex's return on equity of 26.67% beat OrthoPediatrics' return on equity.

Company Net Margins Return on Equity Return on Assets
Pro-Dex13.48% 26.67% 14.95%
OrthoPediatrics -18.92%-6.36%-4.69%

Pro-Dex has a beta of -0.11, meaning that its share price is 111% less volatile than the S&P 500. Comparatively, OrthoPediatrics has a beta of 1.02, meaning that its share price is 2% more volatile than the S&P 500.

In the previous week, OrthoPediatrics had 1 more articles in the media than Pro-Dex. MarketBeat recorded 4 mentions for OrthoPediatrics and 3 mentions for Pro-Dex. Pro-Dex's average media sentiment score of 0.63 beat OrthoPediatrics' score of 0.53 indicating that Pro-Dex is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Pro-Dex
0 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
OrthoPediatrics
1 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

15.3% of Pro-Dex shares are owned by institutional investors. Comparatively, 69.1% of OrthoPediatrics shares are owned by institutional investors. 45.9% of Pro-Dex shares are owned by company insiders. Comparatively, 32.7% of OrthoPediatrics shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

Pro-Dex presently has a consensus target price of $56.00, indicating a potential upside of 97.18%. OrthoPediatrics has a consensus target price of $26.29, indicating a potential upside of 54.35%. Given Pro-Dex's higher possible upside, equities research analysts plainly believe Pro-Dex is more favorable than OrthoPediatrics.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Pro-Dex
0 Sell rating(s)
1 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.50
OrthoPediatrics
1 Sell rating(s)
1 Hold rating(s)
7 Buy rating(s)
0 Strong Buy rating(s)
2.67

Summary

Pro-Dex beats OrthoPediatrics on 9 of the 16 factors compared between the two stocks.

Get Pro-Dex News Delivered to You Automatically

Sign up to receive the latest news and ratings for PDEX and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding PDEX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

PDEX vs. The Competition

MetricPro-DexMED/DENTAL IndustryMedical SectorNASDAQ Exchange
Market Cap$93.15M$18.23B$6.21B$10.81B
Dividend YieldN/A1.64%5.72%4.80%
P/E Ratio10.5218.2531.6030.98
Price / Sales1.402.34595.06133.64
Price / Cash9.0613.3237.2561.86
Price / Book2.533.0312.056.61
Net Income$8.98M$472.95M$3.34B$277.10M
7 Day Performance8.31%2.53%1.94%2.57%
1 Month Performance-16.45%-1.84%6.88%3.20%
1 Year Performance-2.30%-10.08%56.06%33.22%

Pro-Dex Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
PDEX
Pro-Dex
2.7629 of 5 stars
$28.40
+1.2%
$56.00
+97.2%
-2.3%$93.15M$66.59M10.52140News Coverage
Upcoming Earnings
Analyst Forecast
KIDS
OrthoPediatrics
4.558 of 5 stars
$17.51
+7.4%
$26.29
+50.1%
-33.7%$408.70M$204.73M-9.78200Upcoming Earnings
Analyst Forecast
SMLR
Semler Scientific
3.5109 of 5 stars
$26.33
-1.8%
$74.25
+182.0%
-12.6%$405.81M$56.29M10.84120Trending News
Analyst Forecast
TMCI
Treace Medical Concepts
2.1396 of 5 stars
$6.00
+2.0%
$9.83
+63.9%
+46.5%$371.46M$209.36M-7.59250News Coverage
Positive News
Analyst Forecast
DCTH
Delcath Systems
2.694 of 5 stars
$11.35
+8.5%
$24.50
+115.9%
-4.2%$365.90M$37.21M227.0060News Coverage
Analyst Forecast
Analyst Revision
Gap Down
CARL
Carlsmed
N/A$13.13
+0.1%
N/AN/A$348.74M$27.17M0.00100News Coverage
Short Interest ↑
NPCE
NeuroPace
2.7596 of 5 stars
$10.48
+1.9%
$16.60
+58.4%
+65.0%$340.08M$79.91M-12.48170Analyst Forecast
DRTS
Alpha Tau Medical
2.6125 of 5 stars
$3.93
+4.0%
$9.00
+129.0%
+92.3%$320.62MN/A-8.1980News Coverage
Analyst Forecast
TCMD
Tactile Systems Technology
3.8583 of 5 stars
$14.30
+0.6%
$16.83
+17.7%
+6.3%$316.99M$292.98M23.061,037Analyst Forecast
RXST
RxSight
2.1593 of 5 stars
$7.57
+0.8%
$10.00
+32.1%
-82.9%$307.28M$139.93M-9.46220Analyst Forecast
BWAY
Brainsway
2.9461 of 5 stars
$15.16
+0.5%
$18.00
+18.7%
+74.4%$286.58M$41.02M58.31120News Coverage

Related Companies and Tools


This page (NASDAQ:PDEX) was last updated on 10/26/2025 by MarketBeat.com Staff
From Our Partners